Cargando…
Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate
Clomiphene citrate has been traditionally used as the drug of choice in treating women with anovulatory infertility. In the last decade letrozole, an aromatase inhibitor has emerged as alternative ovulation induction agent. Literature confirms that letrozole has a definitive role in anovulatory wome...
Autores principales: | Kamath, Mohan S, George, Korula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148573/ https://www.ncbi.nlm.nih.gov/pubmed/21693034 http://dx.doi.org/10.1186/1477-7827-9-86 |
Ejemplares similares
-
Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trial
por: Kar, Sujata
Publicado: (2012) -
Clomiphene citrate plus letrozole versus clomiphene citrate alone for ovulation induction in infertile women with ovulatory dysfunction: a randomized controlled trial
por: Chera-aree, Pattraporn, et al.
Publicado: (2023) -
The Impact of Letrozole Versus Clomiphene Citrate on Uterine Blood Flow in Patients with Unexplained Infertility
por: Sakhavar, Nahid, et al.
Publicado: (2014) -
Letrozole vs clomiphene citrate in Sudanese patients with infertility secondary to polycystic ovary syndrome
por: Elkhalifa, Warda Salah, et al.
Publicado: (2023) -
Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate
por: Nyboe Andersen, Anders, et al.
Publicado: (2008)